{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:59:06Z","timestamp":1765040346702},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.cll.2011.08.012","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T19:34:35Z","timestamp":1318880075000},"page":"687-698","source":"Crossref","is-referenced-by-count":17,"title":["Chronic Myeloid Leukemia: Current Perspectives"],"prefix":"10.1016","volume":"31","author":[{"given":"Yanming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet D.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2011.08.012_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2011.08.012_bib2","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissue","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.cll.2011.08.012_bib3","first-page":"751","article-title":"The molecular biology of chronic myeloid leukemia","volume":"10","author":"Melo","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.cll.2011.08.012_bib4","first-page":"1497","article-title":"A minute chromosome in human chronic granulocytic leukemia","volume":"132","author":"Nowell","year":"1960","journal-title":"Science"},{"key":"10.1016\/j.cll.2011.08.012_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A new consistent abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.cll.2011.08.012_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","article-title":"A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia","volume":"300","author":"de Klein","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.cll.2011.08.012_bib7","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/315758a0","article-title":"Structural organization of the BCR gene and its role in the Ph' translocation","volume":"315","author":"Heisterkamp","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.cll.2011.08.012_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","article-title":"Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22","volume":"36","author":"Groffen","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.cll.2011.08.012_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of ABL1 and BCR genes in chronic myelogenous leukaemia","volume":"315","author":"Shtivelman","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.cll.2011.08.012_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/MCB.6.2.607","article-title":"The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr\/c-ABL1 transcript","volume":"6","author":"Grosveld","year":"1986","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cll.2011.08.012_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the ABL1 tyrosine kinase on the growth of BCR-ABL1 position cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.cll.2011.08.012_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cll.2011.08.012_bib13","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1182\/blood.V72.1.294.294","article-title":"Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia","volume":"72","author":"Sokal","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib15","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/cncr.25678","article-title":"Peripheral blood monitoring of chronic myeloid leukemia during treatment with Imatinib, second-line agents, and beyond","volume":"117","author":"Lima","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2011.08.012_bib16","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1080\/10428190600783551","article-title":"Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR\/ABL1 fusion to assess cytogenetic remission status in chronic myeloid leukemia","volume":"47","author":"Landstrom","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cll.2011.08.012_bib17","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"Baccarani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib18","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving in Imatinib for chronic myeloid leukemia","volume":"355","author":"Drucker","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2011.08.012_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MOH.0b013e3283366be1","article-title":"Molecular pathogenesis of tyrosine kinase resistance in chronic myeloid leukemia","volume":"17","author":"La Ros\u00e9e","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.cll.2011.08.012_bib20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210 bcr\/ABL1 gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.cll.2011.08.012_bib21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2008-02-130435","article-title":"Whole genome scanning as a cytogenetic tool in hematological malignancies","volume":"112","author":"Maciejewaski","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cll.2011.08.012_bib22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00277-011-1195-2","article-title":"Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after Imatinib therapy in chronic myeloid leukemia","volume":"90","author":"Huh","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cll.2011.08.012_bib23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/gcc.20487","article-title":"Genomic profile of chronic myelogenous leukemia: imbalances associated with disease progression","volume":"46","author":"Brazma","year":"2007","journal-title":"Gene Chrom Cancer"},{"key":"10.1016\/j.cll.2011.08.012_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2164-11-41","article-title":"Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia","volume":"11","author":"Nacheva","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.cll.2011.08.012_bib25","doi-asserted-by":"crossref","first-page":"e1225","DOI":"10.1371\/journal.pone.0001225","article-title":"SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS\/MPD-U and MPD","volume":"2","author":"Gondek","year":"2007","journal-title":"PLOS One"},{"key":"10.1016\/j.cll.2011.08.012_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/gcc.20303","article-title":"Genome-wide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization","volume":"45","author":"Hosoya","year":"2006","journal-title":"Gene Chrom Cancer"},{"key":"10.1016\/j.cll.2011.08.012_bib27","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.dnarep.2006.05.020","article-title":"Chromatin structural elements and chromosomal translocations in leukemia","volume":"5","author":"Zhang","year":"2006","journal-title":"DNA Repair"},{"key":"10.1016\/j.cll.2011.08.012_bib28","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1182\/blood.V99.12.4547","article-title":"Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL1-BCR expression, elevated BCR-ABL1 levels, or karyotypic instability","volume":"99","author":"Huntly","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib29","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1200\/JCO.2009.26.7963","article-title":"Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with Imatinib mesylate: GIMEMA CML Working Party analysis","volume":"28","author":"Castagnetti","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cll.2011.08.012_bib30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1182\/blood.V95.3.738.003k21_738_743","article-title":"Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia","volume":"95","author":"Sinclair","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib31","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V98.6.1732","article-title":"Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia","volume":"98","author":"Huntly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib32","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood-2007-02-074252","article-title":"Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia","volume":"110","author":"Kreil","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib33","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood-2003-01-0123","article-title":"Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia","volume":"102","author":"Huntly","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib34","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2002-09-2763","article-title":"Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions","volume":"102","author":"Huntly","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib35","first-page":"952","article-title":"Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukaemia","volume":"91","author":"Fourouclas","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.cll.2011.08.012_bib36","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood.V98.9.2879","article-title":"ABL1-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia","volume":"98","author":"de la Fuente","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/blood.V81.1.158.158","article-title":"The ABL1-BCR fusion gene is expressed in chronic myeloid leukemia","volume":"81","author":"Melo","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib38","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood-2002-07-2053","article-title":"Emergence of clonal cytogenetic abnormalities in Ph\u2013cells in some CML patients in cytogenetic remission to Imatinib but restoration of polyclonal hematopoiesis in the majority","volume":"101","author":"Bumm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib39","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-01-070045","article-title":"Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during Imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"110","author":"Jabbour","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib40","first-page":"391","article-title":"Chromosome 20q deletion","volume":"135","author":"Sun","year":"2011","journal-title":"Hematopathol"},{"key":"10.1016\/j.cll.2011.08.012_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/gcc.10116","article-title":"Break-point characterization of der(9) deletions in chronic myeloid leukemia patients","volume":"35","author":"Storlazzi","year":"2002","journal-title":"Gene Chrom Cancer"},{"key":"10.1016\/j.cll.2011.08.012_bib42","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/blood-2009-03-212969","article-title":"The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data","volume":"114","author":"Oehler","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cll.2011.08.012_bib43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/leu.2008.154","article-title":"microRNAs and deletion of the derivative chromosome 9 in chronic myeloid leukemia","volume":"23","author":"Chaubey","year":"2009","journal-title":"Leukemia"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271211000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271211000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T03:25:49Z","timestamp":1593141949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271211000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0272271211000783"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2011.08.012","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}